Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Simcere Pharmaceutical Group OCF Margin %?
Simcere Pharmaceutical GroupSMHGF 94 OCF Margin % is 27.66% as of Dec. 2025, which is 61% above its 10-year median of 17.19. GuruFocus rates SMHGF with a GF Score™ of 94/100 and a GF Value™ of $1.26. Among 963 Drug Manufacturers companies, Simcere Pharmaceutical Group ranks better than 88.47% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Simcere Pharmaceutical Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simcere Pharmaceutical Group OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Simcere Pharmaceutical Group's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Simcere Pharmaceutical Group's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Simcere Pharmaceutical Group (SMHGF) has a OCF Margin % of 27.66% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Simcere Pharmaceutical Group and its competitors. This is 61% above median its historical median of 17.19. According to the industry distribution chart, Simcere Pharmaceutical Group ranks #111 out of 963 companies in the Drug Manufacturers industry, placing it in the top 11.5%.
Is Simcere Pharmaceutical Group's OCF Margin % too high?
Simcere Pharmaceutical Group's current OCF Margin % of 27.66% is 61% above median its 10-year median of 17.19. The Drug Manufacturers industry median OCF Margin % is 10.04. Simcere Pharmaceutical Group's value of 27.66% is 175.5% above this industry median. Based on the distribution chart, Simcere Pharmaceutical Group ranks #111 out of 963 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Simcere Pharmaceutical Group has a GF Score™ of 94/100, reflecting its overall financial health beyond just this single metric.
How does Simcere Pharmaceutical Group's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Simcere Pharmaceutical Group ranks #111 out of 963 companies for OCF Margin %. This places Simcere Pharmaceutical Group in the top 12% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 10.04. Simcere Pharmaceutical Group's value of 27.66% is 175.5% above this benchmark. While the company's 10-year median is 17.19 vs. the industry median of 10.04, Simcere Pharmaceutical Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 963 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simcere Pharmaceutical Group's current OCF Margin % of 27.66% is 175.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Simcere Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simcere Pharmaceutical Group's current OCF Margin % is 27.66%, which is 61% above median its own 10-year median of 17.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simcere Pharmaceutical Group stock overvalued right now?
Simcere Pharmaceutical Group (SMHGF) has a current OCF Margin % of 27.66%. The stock's GF Value™ is $1.26, compared to a current price of $1.49 — trading 18.2% above its estimated fair value. The current OCF Margin % is 27.66%, which is 61% above median its 10-year median of 17.19 and 175.5% above the Drug Manufacturers industry median of 10.04. Simcere Pharmaceutical Group's overall GF Score™ is 94/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Simcere Pharmaceutical Group (SMHGF), the current OCF Margin % is 27.66% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simcere Pharmaceutical Group (SMHGF) Overvalued in 2026?
Based on GuruFocus' analysis, Simcere Pharmaceutical Group stock appears to be overvalued.
The current stock price of $1.49 is trading 18.2% above its estimated GF Value™ of $1.26.
Key valuation signals for SMHGF:
OCF Margin %: 27.66% (61% above median its 10-year median of 17.19)
GF Value™: $1.26 vs. price of $1.49 (18.2% above fair value)
Industry Position: 175.5% above the Drug Manufacturers median (#111 of 963)
No single metric tells the full story. See the SMHGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production, and commercialization of pharmaceuticals focused on generic pharmaceuticals. The company has a diversified product portfolio focused on therapeutic areas, including, neuroscience, anti-oncology, autoimmune, and antiinfection. The company's products include Endostar, Enweida, Enzeshu, Iremod, Quviviq, Cosela, Sanbexin and Others.
94GF Score
Get the complete analysis for SMHGF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SMHGF has been successfully added to your 
